Latest Developments in Precision Medicine and Molecular Detection
©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
LATEST
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
2023-03-22